β-cell transplantation restores metabolic control and quality of life in a patient with subcutaneous insulin resistance

Diabetes Care

Volumn 27, Issue 9, 2004, Pages 2243-2244

  Gillard, Pieter ^a,c   Ling, Zhidong ^a   Lannoo, Matthias ^a   Maes, Bart ^b   Maleux, Geert ^b   Pipeleers, Daniel ^a   Keymeulen, Bart ^a   Mathieu, Chantal ^b  

^a VRIJE UNIVERSITEIT BRUSSEL   (Belgium)

^b UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^c UNIVERSITY HOSPITAL BRUSSELS   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

C PEPTIDE; GLUCOSE; HEMOGLOBIN A1C; IMMUNOSUPPRESSIVE AGENT; INSULIN; INSULIN LISPRO; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TACROLIMUS; THYMOCYTE ANTIBODY;

ADULT; ARTICLE; CASE REPORT; FOLLOW UP; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN PUMP; INSULIN RESISTANCE; INSULIN TREATMENT; METABOLIC REGULATION; NECROBIOSIS LIPOIDICA; PANCREAS ISLET BETA CELL; PANCREAS ISLET TRANSPLANTATION; QUALITY OF LIFE;

ADULT; DIABETES MELLITUS, TYPE 1; HUMANS; INSULIN INFUSION SYSTEMS; INSULIN RESISTANCE; ISLETS OF LANGERHANS TRANSPLANTATION; LEG; NECROSIS; QUALITY OF LIFE; TREATMENT OUTCOME;

EID: 4444369763     PISSN: 01495992     EISSN: None     Source Type: Journal    
DOI: 10.2337/diacare.27.9.2243     Document Type: Article

References (9)

1. Keymeulen B, Ling Z, Gorus FK, Delvaux G, Bouwens L, Grupping A, Hendrieckx C, Pipeleers-Marichal M, Van Schravendijk C, Salmela K, Pipeleers DG: Implantation of standardized beta-cell grafts in a liver segment of IDDM patients: graft and recipients characteristics in two cases of insulin-independence under maintenance immunosuppression for prior kidney graft. Diabetologia 41:452-459, 1998
2. Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Wamock GL, Kneteman NM, Rajotte RV: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med 343:230-238, 2000
3. Goss JA, Schock AP, Brunicardi FC, Goodpastor SE, Garber AJ, Soltes G, Barth M, Froud T, Alejandro R, Ricordi C: Achievement of insulin independence in three consecutive type-1 diabetic patients via pancreatic islet transplantation using islets isolated at a remote islet isolation center. Transplantation 74:1761-1766, 2002
4. Markmann JF, Deng S, Huang X, Desai NM, Velidedeoglu EH, Lui C, Frank A, Markmann E, Palanjian M, Brayman K, Wolf B, Bell E, Vitamaniuk M, Doliba N, Matschinsky F, Barker CF, Naji A: Insulin independence following isolated islet transplantation and single islet infusions. Ann Surg 237:741-749, 2003 [discussion 749-750]
5. Campbell IW, Kritz H, Najemnik C, Hagmueller G, Irsigler K: Treatment of type I diabetic with subcutaneous insulin resistance by a totally implantable insulin infusion device "Infusaid." Diabetes Res 1: 83-88, 1984
6. Goldfine AB, Kahn CR: Insulin allergy and insulin resistance. Curr Ther Endocrinol Metab 5:461-464, 1994
7. Lahtela JT, Knip M, Paul R, Antonen J, Salmi J: Severe antibody-mediated human insulin resistance: successful treatment with the insulin analog lispro: a case report. Diabetes Care 20:71-73, 1997
8. Cohen O, Yaniv R, Karasik A, Trau H: Necrobiosis lipoidica and diabetic control revisited. Med Hypotheses 46:348-350, 1996
9. Darvay A, Acland KM, Russell-Jones R: Persistent ulcerated necrobiosis lipoidica responding to treatment with cyclosporin. Br J Dermatol 141:725-727, 1999